cepharanthine has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, S; Che, XF; Furukawa, T; Haraguchi, M; Ikeda, R; Jeung, HC; Nakamura, K; Okumura, H; Shibayama, Y; Sumizawa, T; Takeda, Y; Ushiyama, M; Yamada, K; Yamaguchi, T; Zheng, CL | 1 |
| Aogi, K; Hirabayashi, N; Nishiyama, M; Saeki, S; Toge, T | 1 |
2 other study(ies) available for cepharanthine and Cancer of Pancreas
| Article | Year |
|---|---|
Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells.
Topics: Alkaloids; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Pancreatic Neoplasms; Tumor Cells, Cultured; Vincristine | 2005 |
[Combination of a biscoclaurine alkaloid, cepharanthine, and anticancer agents: effects and mechanism in human gastric and pancreatic carcinoma cell lines].
Topics: Alkaloids; Antineoplastic Agents; Benzylisoquinolines; Cell Division; Doxorubicin; Drug Synergism; Fluorouracil; Humans; Leukemia, Myeloid; Membrane Potentials; Mitomycin; Pancreatic Neoplasms; Stomach Neoplasms; Tumor Cells, Cultured | 1991 |